Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar 29:2022:2235025.
doi: 10.1155/2022/2235025. eCollection 2022.

Opioid-Free Labor Analgesia: Dexmedetomidine as an Adjuvant Combined with Ropivacaine

Wei Gao  1 , Jie Wang  1 , Zhiguo Zhang  1 , Haiying He  2 , Huiwen Li  1 , Ruili Hou  3 , Liping Zhao  4 , Daniel Muthee Gaichu  5
Affiliations
Randomized Controlled Trial

Opioid-Free Labor Analgesia: Dexmedetomidine as an Adjuvant Combined with Ropivacaine

Wei Gao et al. J Healthc Eng. .

Retraction in

Abstract

Background: Side effects of the use of opioid analgesics during painless delivery are the main factors that affect rapid postpartum recovery. Opioid use can result in dangerous respiratory depression in the patient. Opioids can also disrupt the baby's breathing and heart rate. The nonopioid analgesic dexmedetomidine, a new a2-adrenergic agonist, possesses higher selectivity, greater analgesic effects, and fewer side effects. Moreover, epidural administration of dexmedetomidine also reduces local anesthetic consumption.

Objective: Our study aims to compare the analgesic effects as well as the side effects of ropivacaine with dexmedetomidine against sufentanyl as an epidural labor analgesia.

Methods: This study is a randomized, double-blinded, controlled trial (registration no. ChiCTR2200055360) involving 120 primiparous (a woman who has given birth once), singleton pregnancy women who are greater than 38 weeks into gestation and have requested epidural labor analgesia. The participants were randomized to receive 0.1% ropivacaine with sufentanyl (0.4 μg/ml) or dexmedetomidine (0.4 μg/ml). The primary outcomes included Visual Analogue Score (VAS), duration of first epidural infusions, the requirement of additional PCEA bolus, and adverse reactions during labor analgesia.

Results: Of the 120 subjects who consented, 91 parturient women (women in the condition of labor) had complete data for analysis. Demographics and VAS, as well as maternal and fetal outcomes, were similar between the groups. The duration of first epidural infusions in dexmedetomidine was significantly longer than sufentanyl (median value: 115 vs 68 min, P < 0.01); the parturient women who received dexmedetomidine and who required additional PCEA bolus were fewer in comparison to those who received sufentanyl (27.5% vs 49.0%, P < 0.05). Furthermore, the incidence of pruritus in the dexmedetomidine group was lower in comparison to the sufentanyl group (0% vs 11.8%, P < 0.05).

Conclusions: Dexmedetomidine, a nonopioid, is superior to the opioid analgesic sufentanyl in providing a prolonged analgesic effect as an epidural during labor. It also reduces local anesthetic consumption and has fewer side effects. The trial is registered with ChiCTR2200055360.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Participant flow diagram.
Figure 2
Figure 2
VAS of two groups at T0, T1, and T2. P < 0.05 was considered statistically significant.
Figure 3
Figure 3
Duration of the first epidural infusions of the two groups.
Figure 4
Figure 4
Maternal side effects and those requiring additional PCEA bolus from the two groups.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Miles E. T. C., Stone J. P. Pain relief during labour. The Lancet . 2019;394(10198):p. e14. doi: 10.1016/s0140-6736(19)30709-3. - DOI - PubMed
    1. Arkoosh V. A., Palmer C. M., Yun E. M., et al. A randomized, double-masked, multicenter comparison of the safety of continuous intrathecal labor analgesia using a 28-gauge catheter versus continuous epidural labor analgesia. The Journal of the American Society of Anesthesiologists . 2008;108(2):286–298. doi: 10.1097/01.anes.0000299429.52105.e5. - DOI - PubMed
    1. Zhi M., Diao Y., Liu S., et al. Sufentanil versus fentanyl for pain relief in labor involving combined spinal-epidural analgesia: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology . 2020;76(4):501–506. doi: 10.1007/s00228-019-02806-x. - DOI - PubMed
    1. Lirk P., Rathmell J. P. Opioid-free anaesthesia: Con: it is too early to adopt opioid-free anaesthesia today. European Journal of Anaesthesiology . 2019;36(4):250–254. doi: 10.1097/eja.0000000000000965. - DOI - PubMed
    1. Abdelrahman T. N., Algharabawy W. S. Opioid-free general anaesthesia for transthoracic oesophagectomy: does it improve postoperative analgesia and other recovery criteria? A prospective randomised study. Ain-Shams Journal of Anaesthesiology . 2021;13(1):1–10. doi: 10.1186/s42077-021-00170-6. - DOI

Publication types

LinkOut - more resources